comparemela.com
Home
Live Updates
Positive results from the Phase II study of uTRACE in brain cancer presented at the World Molecular Imaging Congress (WMIC) 2023 in Prague : comparemela.com
Positive results from the Phase II study of uTRACE in brain cancer presented at the World Molecular Imaging Congress (WMIC) 2023 in Prague
/PRNewswire/ -- Curasight A/S ("Curasight" or the "Company" - TICKER: CURAS) announces today that the previously announced results from the...
Related Keywords
Copenhagen ,
Køavn ,
Denmark ,
Prague ,
Praha ,
Hlavníesto ,
Czech Republic ,
Aleena Azam ,
Ulrich Krasilnikoff ,
World Molecular Imaging Congress ,
University Of Copenhagen ,
Primary Gliomas ,
Prognostic Value ,
Targeted Radionuclide ,
Molecular Imaging ,
Springer Publisher ,
Positron Emissions Tomography ,
Radionuclide Therapy ,
Curasight ,
comparemela.com © 2020. All Rights Reserved.